B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events
about
Pathogenesis of systemic lupus erythematosusB cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus.Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayT and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice.The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLEPathogenesis of human systemic lupus erythematosus: recent advances.T-cell and B-cell signaling biomarkers and treatment targets in lupus.Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.Getting Syk: spleen tyrosine kinase as a therapeutic target.Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.Recent progress in the understanding of B-cell functions in autoimmunity.Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus.Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53From T to B and back again: positive feedback in systemic autoimmune disease.The Orai-1 and STIM-1 complex controls human dendritic cell maturationEvidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients.Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolismB Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.Systemic lupus erythematosus: from genes to organ damage.Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideTissue-specific expression of human calcineurin-binding protein 1 in mouse synovial tissue can suppress inflammatory arthritis.Targeting CD40L: a promising therapeutic approach.Reduced receptor editing in lupus-prone MRL/lpr miceAdvances in human B cell phenotypic profiling.CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus.Impaired early B cell tolerance in patients with rheumatoid arthritis.B Cells, Antibodies, and More.Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function.A role for Fli-1 in B cell proliferation: implications for SLE pathogenesisInflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.Altered B cell receptor signaling in human systemic lupus erythematosusEzrin tunes the magnitude of humoral immunity.Prolactin alters the mechanisms of B cell tolerance induction.The Epstein-Barr virus and systemic lupus erythematosus.Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.Antigen receptor signaling in the rheumatic diseasesTargeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.
P2860
Q24672873-43054F92-CD90-4A5A-B36D-97D8A7AE7059Q24805469-EC91A808-B34E-48AD-B06C-4DB0B1908650Q26746697-1178528A-F5EF-4543-89D1-324E8EEF8464Q30494990-3948D59D-AE0C-479F-9723-C90A0F3F6480Q31089201-9CBE6E9B-6663-4B4F-BA1D-F1C33B1B9EC2Q33608479-3AB5EB45-36FC-4886-97D8-9FE4A7F60037Q33614719-D727DBCE-D667-4BDB-938F-431A74DC7204Q33664927-39F3F5E3-B29A-48B2-96CB-AAF147ACD539Q33718893-545AD10B-D848-487A-81EC-228FF00458DBQ33895460-A45C3183-D379-4458-9E15-F5562E8E25B7Q33993750-8B18DF38-2909-49DE-8751-FFDC0DCF6620Q34166502-A3D664E6-E20C-4738-8E57-562AB6B05F67Q34299834-36ADE695-A0C7-4558-BCC7-B6F90FBAF6B0Q34476578-A0CE006D-0097-408C-A40C-F04E4206E3D8Q34487653-0511BC89-36CC-495E-8155-9A54E513D660Q34572168-27327A67-9326-4420-96D3-06AB435DB74AQ34734948-2A23B159-7306-4005-91DF-D98113EAD50DQ34971055-0730EF32-E9DA-4875-81FD-E41ABDDF092EQ34990559-F7C9195A-6596-424F-957F-130B07E0C4FCQ35102984-4CDC036D-1AF3-40D5-9E38-D21A264A7F43Q35156161-F4694DD1-B21B-49D5-B84B-E9F6615A10DDQ35309470-B5448876-F0A7-48C7-933F-B7F6DE9AC8D3Q35664985-14D955F9-CE0D-4063-B601-D95063943B25Q35830859-C896AFA5-8571-4E6F-B8D8-3B70A643797DQ36229153-9D183639-A541-4045-99B4-3D75875CEF0AQ36307080-99C96EF1-0803-416A-8C04-5CA2C1FFCF27Q36376237-4D8B4129-EECC-4C70-BD16-B4805E51161EQ36402969-A96BF423-8AB1-4559-B123-E734F5BFADA5Q36432935-34D6EC79-121C-4387-A936-FDC85F91A94EQ36687918-1427CCFF-F0FC-41AB-812F-29513C0D12F8Q36925450-4921E53F-2AD9-409A-9187-1B89200CE706Q36975464-99B1FB05-2A3C-4F94-9780-B6C69AF1A26FQ37250671-2EECF2E1-9845-44E1-A0B9-6B1822569320Q37256630-EEFFC41A-1CFB-43B5-A3B3-30B01581A276Q37323624-D4CCBE34-760E-421A-9E83-FEDFDDE3209FQ37375991-8AE305D9-3794-4FCB-99C7-166FDDD6801EQ37380253-736A8197-063B-47F9-AAC7-8F3FB3EA4A12Q37396708-A8C8FE04-CB54-4D98-825C-391A65D2E5DEQ37397652-BC4C13E8-D2A1-4C57-B585-0175410D5604Q37577890-187F53A5-56BC-4D7F-ABBB-6212913424E8
P2860
B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B cells from patients with sys ...... rly signal transduction events
@en
B cells from patients with sys ...... ly signal transduction events.
@nl
type
label
B cells from patients with sys ...... rly signal transduction events
@en
B cells from patients with sys ...... ly signal transduction events.
@nl
prefLabel
B cells from patients with sys ...... rly signal transduction events
@en
B cells from patients with sys ...... ly signal transduction events.
@nl
P2093
P2860
P356
P1476
B cells from patients with sys ...... rly signal transduction events
@en
P2093
P2860
P304
P356
10.1172/JCI119073
P407
P577
1996-12-01T00:00:00Z